Birdwatch Archive

Birdwatch Note

2023-03-04 16:18:06 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING

A BC company was granted a license to manufacture and distribute medical grade cocaine which is not uncommon. Cocaine has many applications in medicine. Mr. Poilievre’s assertion is untrue. https://ca.news.yahoo.com/cocaine-decriminalization-drugs-british-columbia-health-canada-adastra-labs-232358591.html

Written by F9BA0544FB2D46CF3937C0D4E24C3DA7B1376A7695546E6D6682A5A00BBABBF6
Participant Details

Original Tweet

Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1631736694926917633

Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.

All Information

  • ID - 1632052808798154753
  • noteId - 1632052808798154753
  • participantId - F9BA0544FB2D46CF3937C0D4E24C3DA7B1376A7695546E6D6682A5A00BBABBF6
  • noteAuthorParticipantId -
  • createdAtMillis - 1677946686351
  • tweetId - 1631736694926917633
  • classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
  • believable -
  • harmful -
  • validationDifficulty -
  • misleadingOther - 0
  • misleadingFactualError - 1
  • misleadingManipulatedMedia - 0
  • misleadingOutdatedInformation - 0
  • misleadingMissingImportantContext - 1
  • misleadingUnverifiedClaimAsFact - 0
  • misleadingSatire - 0
  • notMisleadingOther - 0
  • notMisleadingFactuallyCorrect - 0
  • notMisleadingOutdatedButNotWhenWritten - 0
  • notMisleadingClearlySatire - 0
  • notMisleadingPersonalOpinion - 0
  • trustworthySources - 1
  • summary
    • A BC company was granted a license to manufacture and distribute medical grade cocaine which is not uncommon. Cocaine has many applications in medicine. Mr. Poilievre’s assertion is untrue. https://ca.news.yahoo.com/cocaine-decriminalization-drugs-british-columbia-health-canada-adastra-labs-232358591.html

Note Status History

createdAt timestampMillisOfFirstNonNMRStatus firstNonNMRStatus timestampMillisOfCurrentStatus currentStatus timestampMillisOfLatestNonNMRStatus mostRecentNonNMRStatus participantId
2023-03-04 16:18:06 UTC
(1677946686351)
1969-12-31 23:59:59 UTC
(-1)
2023-03-07 02:11:29 UTC
(1678155089929)
NEEDS_MORE_RATINGS 1969-12-31 23:59:59 UTC
(-1)

Note Ratings

rated at rated by
2023-03-04 22:51:53 -0600 062AC91D53CC4BF58744F48A1D655FBD46B212DCCF09E4E15D32F3A1678A0358 Rating Details
2023-03-08 10:12:24 -0600 1E63C4F17963B9C5B4489BFDF29FE99946F4AFDBE9F44C5F9A9F6119EB7A78A4 Rating Details
2023-03-05 06:39:45 -0600 32961DFCF69C7286C032555D38E43D996EACE64FD298A1D556F0B8E4A5022691 Rating Details
2023-03-04 12:18:20 -0600 33ADA05430AF9F021EF972F9B30E425AA149B49E8E336B8CF12DC4004438B564 Rating Details
2023-03-04 13:14:42 -0600 3922021E2B4C1A4B610B8FAFE0447925B4441B7A397CBAE1E446B9DE65C2A8E3 Rating Details
2023-03-04 14:35:37 -0600 45060ED935D102E05C21C743FE433C0B17B27D8FCF69CED01A2AD3F9AB2815B1 Rating Details
2023-03-04 10:43:47 -0600 45B8EF43682258D990F1C39DD9C1C131E030B7B116A1A874CAD37AED55F98C04 Rating Details
2023-03-05 00:23:47 -0600 4F57BCCB80A658264EE30D251381B4AFBF8E49CA6E2CE0723AE830280D085DE8 Rating Details
2023-03-05 02:42:07 -0600 78357D46F6554A11287C08A3273858EC308C337D88A8C2CE9B7A36601938BE5B Rating Details
2023-03-04 12:20:35 -0600 903BE1C6717B8C7EC593D92456155A14938E975607959F9BA30E21B8A2EAA7AC Rating Details
2023-03-04 11:27:29 -0600 A3C762BEE3C5EC33CEA5BA189DD3E7E99B1086EAE4832316B3F613A11D9214F5 Rating Details
2023-03-05 10:30:23 -0600 A60B5131680C3A028B65501660BDF40DE1208AD48837729EE21A0853434178CC Rating Details
2023-03-04 21:07:07 -0600 B5FEE1C7F02671E2466AE0184315222BE9F827034DA0D608839BE86F8B7D554A Rating Details
2023-03-04 13:19:58 -0600 C378931E048482D2BFDF00DC95644D6377CBCB812C79FF87D77B5E48595B3DA3 Rating Details
2023-03-29 16:06:52 -0500 Rating Details
2023-03-08 10:12:24 -0600 Rating Details
2023-03-04 10:43:47 -0600 Rating Details
2023-03-04 12:18:20 -0600 Rating Details
2023-03-05 06:39:45 -0600 Rating Details
2023-03-04 22:51:53 -0600 Rating Details
2023-03-05 10:30:23 -0600 Rating Details
2023-03-04 21:07:07 -0600 Rating Details
2023-03-04 13:19:58 -0600 Rating Details
2023-03-04 14:35:37 -0600 Rating Details
2023-03-04 11:27:29 -0600 Rating Details
2023-03-05 02:42:07 -0600 Rating Details
2023-03-04 13:14:42 -0600 Rating Details
2023-03-05 00:23:47 -0600 Rating Details
2023-03-04 12:20:35 -0600 Rating Details
2023-03-29 16:06:52 -0500 Rating Details